Loading...
Intranasal lidocaine to block the sphenopalatine ganglion in refractory chronic migraines: a case report
Bazan, Marlon
Bazan, Marlon
Citations
Altmetric:
Files
Loading...
Bazan_2018
Adobe PDF, 956 KB
Authors
Other Names
Location
Time Period
Advisors
Original Date
Digitization Date
Issue Date
2018-04-27
Type
Abstract
Genre
Keywords
Subjects (LCSH)
Citation
Bazan, Marlon. 2018. Intranasal lidocaine to block the sphenopalatine ganglion in
refractory chronic migraines: a case report -- In Proceedings: 14th Annual Symposium on Graduate Research and Scholarly Projects. Wichita, KS: Wichita State University, p. 13
Abstract
Intranasal lidocaine to treat chronic migraines may be a viable option after first and second line treatments are exhausted. It is thought to work by blocking the sphenopalatine ganglion. Although data from randomized placebo-controlled trials are inconsistent, intranasal lidocaine is rapid, safe, and easily implemented in an outpatient setting. This is a case report of a 58-year-old female who initially presented with migraines and associated phonophobia and photophobia who
failed multiple treatment options including topiramate, propranolol, ketorolac, promethazine, nortriptyline, botulinum toxin injections, daith piercing, lamotrigine, and narcotics. She responded favorably to lidocaine 4% intra-nasally. She continued receiving this treatment for more than 12 months before it ultimately diminished in efficacy.
Table of Contents
Description
Presented to the 14th Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held at the Rhatigan Student Center, Wichita State University, April 27, 2018.
Research completed in the Department of Physician Assistant, College of Health Professions
Research completed in the Department of Physician Assistant, College of Health Professions
Publisher
Wichita State University
Journal
Book Title
Series
GRASP
v. 14
v. 14